AZN icon

AstraZeneca

1,138 hedge funds and large institutions have $33.8B invested in AstraZeneca in 2024 Q1 according to their latest regulatory filings, with 120 funds opening new positions, 485 increasing their positions, 340 reducing their positions, and 94 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding

Funds holding:

0.45% less ownership

Funds ownership: 32.57%32.12% (-0.45%)

1% less capital invested

Capital invested by funds: $34B → $33.8B (-$235M)

8% less funds holding in top 10

Funds holding in top 10: 1312 (-1)

Holders
1,138
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
12
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$480M
Puts
$470M
Net Calls
Net Calls Change

Top Sellers

1 -$903M
2 -$659M
3 -$157M
4
N
Nuveen
North Carolina
-$129M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$103M
Name Holding Trade Value Shares
Change
Change in
Stake
301
$2.89M
302
$2.88M
303
$2.83M
304
$2.83M
305
$2.7M
306
$2.7M
307
$2.68M
308
$2.68M
309
$2.67M
310
$2.65M
311
$2.63M
312
$2.6M
313
$2.59M
314
$2.58M
315
$2.55M
316
$2.55M
317
$2.51M
318
$2.5M
319
$2.47M
320
$2.46M
321
$2.45M
322
$2.44M
323
$2.39M
324
$2.38M
325
$2.35M